Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,989 | 3,932 | -3,127 | -2,871 | 14,313 |
| Depreciation Amortization | 5,185 | 2,956 | 1,976 | 982 | 5,131 |
| Income taxes - deferred | -1,511 | -1,671 | -916 | -90 | 152 |
| Accounts receivable | -3,113 | -4,195 | 1,223 | -6,487 | 18,481 |
| Accounts payable and accrued liabilities | 806 | 7,606 | 8,246 | 4,294 | -4,455 |
| Other Working Capital | 816 | -4,164 | 8,264 | -8,835 | 14,392 |
| Other Operating Activity | 35,325 | 25,273 | 8,444 | 16,165 | 7,972 |
| Operating Cash Flow | $49,497 | $29,737 | $24,110 | $3,158 | $55,986 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -747 | -577 | -376 | -472 | -777 |
| Purchase Of Investment | -17,500 | -17,500 | -17,500 | -17,500 | N/A |
| Investing Cash Flow | $-18,247 | $-18,077 | $-17,876 | $-17,972 | $-777 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 110,000 | 110,000 | 110,000 | 110,000 | N/A |
| Debt Repayment | -115,000 | -110,000 | -110,000 | -1,000 | -6,000 |
| Common Stock Issued | 3,654 | 555 | 513 | 330 | 260 |
| Common Stock Repurchased | -34,999 | -27,999 | -4,999 | -999 | -17,961 |
| Other Financing Activity | -1,525 | -4,310 | -3,310 | -1,276 | -524 |
| Financing Cash Flow | $-37,870 | $-31,754 | $-7,796 | $107,055 | $-24,225 |
| Beginning Cash Position | 109,775 | 109,775 | 109,775 | 109,775 | 78,791 |
| End Cash Position | 103,155 | 89,681 | 108,213 | 202,016 | 109,775 |
| Net Cash Flow | $-6,620 | $-20,094 | $-1,562 | $92,241 | $30,984 |
| Free Cash Flow | |||||
| Operating Cash Flow | 49,497 | 29,737 | 24,110 | 3,158 | 55,986 |
| Capital Expenditure | -747 | -577 | -376 | -472 | -777 |
| Free Cash Flow | 48,750 | 29,160 | 23,734 | 2,686 | 55,209 |